Analysis of Postural Transitions in Subjects Affected by Parkinson Disease

February 19, 2024 updated by: Fondazione Don Carlo Gnocchi Onlus
This observational trial aims to evaluate the effect of Rehabilitation on Postural Transfers (PTs) in subjects affected by Parkinson Disease. The PTs are evaluated by an inertial sensor (a device composed by an accelerometer, a gyroscope and a magnetometer) attached to the subjects. The data obtained by the inertial sensor are kinematic (e.g. acceleration and angular speed) and spatiotemporal parameters (e.g. time to completion and velocity). Additional clinical evaluations are carried out at the beginning and end of the rehabilitative intervention.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • BS
      • Rovato, BS, Italy, 25038
        • Recruiting
        • Fondazione Don Carlo Gnocchi
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Population of subjects affected by Parkinson Disease

Description

Inclusion Criteria:

  • Subjects with Idiopathic Parkinson's Disease;
  • Subjects should be in a positive therapeutic window or in the ON phase during the evaluations;
  • Subjects must be able to walk at least 10 meters independently with or without any walking aid

Exclusion Criteria:

  • Non-clinically stable subjects;
  • Subjects in OFF phase during the evaluations;
  • Other neurological conditions (e.g. stroke, peripheral neuropathies, etc.);
  • Other pathologies that can negatively influence the subject's walking ability (e.g. surgery at the lower limbs in the previous 6 months, important deformities at the lower limbs, etc.)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Parkinson Disease
Rehabilitation according to Physiotherapy and Occupational Therapy European Guidelines for Parkinson Disease.
Intervention focused on balance, gait and postural transfers rehabilitation. 20 session of 90 minutes (60 minutes of physiotherapy and 30 minutes of occupational therapy), 2 times a week, for 10 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in execution time of Postural Transfers
Time Frame: Change from Baseline at 10 weeks
The execution time is measured via an inertial measurement unit attached to the back of the patient
Change from Baseline at 10 weeks
Change of execution velocity of Postural Transfers
Time Frame: Change from Baseline at 10 weeks
The execution velocity is measured via an inertial measurement unit attached to the back of the patient. Specifically the velocity are measured as the Root Mean Square of gyroscope signal.
Change from Baseline at 10 weeks
Change of antero-posterior acceleration during Postural Transfers execution
Time Frame: Change from Baseline at 10 weeks
The antero-posterior acceleration is measured via an inertial measurement unit attached to the back of the patient.
Change from Baseline at 10 weeks
Change of superior-inferior acceleration during Postural Transfers execution
Time Frame: Change from Baseline at 10 weeks
The superior inferior acceleration is measured via an inertial measurement unit attached to the back of the patient.
Change from Baseline at 10 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Change in Time Up and Go Test
Time Frame: Change from baseline at 10 weeks
Change from baseline at 10 weeks
Change in 10 meter walking test
Time Frame: Change from baseline at 10 weeks
Change from baseline at 10 weeks
Change in Berg Balance Scale Score
Time Frame: Change from baseline at 10 weeks
Change from baseline at 10 weeks
Change in Short-Form 12 score
Time Frame: Change from baseline at 10 weeks
Change from baseline at 10 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Riccardo Buraschi, PT, Irccs Fondazione Don Carlo Gnocchi

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 18, 2022

Primary Completion (Estimated)

April 1, 2024

Study Completion (Estimated)

April 1, 2024

Study Registration Dates

First Submitted

April 4, 2022

First Submitted That Met QC Criteria

April 12, 2022

First Posted (Actual)

April 15, 2022

Study Record Updates

Last Update Posted (Actual)

February 20, 2024

Last Update Submitted That Met QC Criteria

February 19, 2024

Last Verified

September 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson Disease

Clinical Trials on Rehabilitation

3
Subscribe